We are live on ! Find out more
DII

Domini Impact Investments Portfolio holdings

AUM $7.59M
1-Year Est. Return 47.68%
This Fund
S&P 500
This Quarter Est. Return
-19.34%
1 Year Est. Return
+47.68%
3 Year Est. Return
+231.06%
5 Year Est. Return
+291.89%
10 Year Est. Return
–
AUM
$6.12M
AUM Growth
-$361K
Cap. Flow
+$1.57M
Cap. Flow %
25.66%
Top 10 Hldgs %
69.16%
Holding
19
New
2
Increased
17
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SUNE
SUNEDISON, INC COM
SUNE
+$396K
2
WOLF icon
Wolfspeed
WOLF
+$213K
3
CLDX icon
Celldex Therapeutics
CLDX
+$147K
4
GILD icon
Gilead Sciences
GILD
+$120K
5
STKL
SunOpta
STKL
+$90.9K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 51.98%
2 Technology 24.28%
3 Consumer Staples 12.15%
4 Industrials 11.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$162B
$864K 14.12%
8,798
+1,081
+14% +$120K
OSUR icon
2
OraSure Technologies
OSUR
$273M
$476K 7.78%
107,254
+13,167
+14% +$68.7K
AYI icon
3
Acuity Brands
AYI
$10.1B
$446K 7.29%
2,541
+312
+14% +$60.6K
FSLR icon
4
First Solar
FSLR
$22.1B
$412K 6.73%
9,632
+1,183
+14% +$54.7K
STKL
5
DELISTED
SunOpta
STKL
$397K 6.49%
81,596
+10,024
+14% +$90.9K
OLED icon
6
Universal Display
OLED
$3.81B
$376K 6.14%
11,096
+1,368
+14% +$57.1K
NGVC icon
7
Vitamin Cottage Natural Grocers
NGVC
$729M
$347K 5.67%
15,311
+1,885
+14% +$45.3K
ADSK icon
8
Autodesk
ADSK
$47.7B
$337K 5.51%
7,641
+940
+14% +$47.2K
NTUS
9
DELISTED
Natus Medical Inc
NTUS
$289K 4.72%
7,331
+903
+14% +$38.4K
ALR
10
DELISTED
Alere Inc
ALR
$289K 4.72%
6,005
+739
+14% +$38.3K
SRPT icon
11
Sarepta Therapeutics
SRPT
$1.68B
$278K 4.54%
8,664
+1,068
+14% +$36.2K
HOLX
12
DELISTED
Hologic
HOLX
$272K 4.44%
6,960
+855
+14% +$33.9K
AMRC icon
13
Ameresco
AMRC
$1.12B
$263K 4.3%
44,712
+5,504
+14% +$35.1K
VYNT
14
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$235K 3.84%
200
+24
+14% +$36.7K
SGEN
15
DELISTED
Seagen Inc. Common Stock
SGEN
$226K 3.69%
5,870
+720
+14% +$32.4K
CLDX icon
16
Celldex Therapeutics
CLDX
$2.8B
$211K 3.45%
1,336
+521
+64% +$147K
WOLF icon
17
Wolfspeed
WOLF
$1.24B
$202K 3.3%
+8,341
New +$213K
SUNE
18
DELISTED
SUNEDISON, INC COM
SUNE
$159K 2.6%
+22,082
New +$396K
VSTM icon
19
Verastem
VSTM
$534M
$42K 0.69%
1,936
+238
+14% +$18.8K

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
PIM
Partner Investment Management San Francisco, California $13.9M AUM 55.92% 1-Year Est. Return
MCM
Marcato Capital Management San Francisco, California $1.2M AUM 91.17% 1-Year Est. Return
SLI
Symetra Life Insurance Bellevue, Washington $512K AUM
CWSR
Chessman Wealth Strategies RIA Dallas, Texas $211K AUM 15.56% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return

Domini Impact Investments's Q3 2015 Portfolio in Review

As of Q3 2015, Domini Impact Investments held 19 positions worth $6.12M, down 5.6% from $6.48M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Domini Impact Investments deployed $1.57M of net new capital in Q3 2015, opening 2 new positions and adding to 17 existing holdings. Its largest new stake was SUNEDISON, INC COM: 22,082 shares worth $159K.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 53% a quarter earlier, followed by Technology and Consumer Staples.

  • Domini Impact Investments's largest Q3 2015 buy was SUNEDISON, INC COM: 22,082 shares worth $159K.
  • Domini Impact Investments added most to Celldex Therapeutics in Q3 2015, an estimated $147K increase.
  • Domini Impact Investments's ten largest holdings make up 69% of its $6.12M portfolio in Q3 2015.
  • Domini Impact Investments opened 2 new positions and closed 0 in Q3 2015.
  • Domini Impact Investments's portfolio value fell 5.6% quarter-over-quarter to $6.12M.

Based on Domini Impact Investments's 13F filing for Q3 2015, filed 12 Nov 2015.